Baker Briefing: The Biden Administration Takes On Tranq
Table of Contents
Author(s)
Joe Barnes
Bonner Means Baker FellowKatharine Neill Harris
Alfred C. Glassell, III, Fellow in Drug PolicyThis week, the White House announced a new initiative to tackle the growing use of fentanyl laced with xylazine — known to many as "tranq." This combination of drugs poses an alarming and significant threat to public health. The CDC reported last month that the percentage of fatal opioid overdoses in which xylazine was detected increased by 276% in just three years.
Drug policy fellow Katharine Neill Harris discusses the rise in xylazine-laced fentanyl, as well as federal, state and local policy approaches to curbing the nation’s overdose epidemic.
Discussants:
- Joe Barnes, Bonner Means Baker Fellow, Baker Institute
- Katharine Neill Harris, Ph.D., Alfred C. Glassell, III, Fellow in Drug Policy, Baker Institute
About Baker Briefing
Baker Briefing is a podcast that tackles the most critical foreign and domestic policy issues of the day in conversations with experts at the Baker Institute. Hosted by the Honorable David M. Satterfield, director of the Baker Institute, new episodes are released weekly.
Attend a Live Recording
Each episode of Baker Briefing is recorded in front of a live audience at Rice University in Houston, Texas. You can attend live recordings by joining the Baker Roundtable, the Baker Institute’s membership forum.